Early Phase Cancer Immunotherapy / edited by Sandip Pravin Patel, Razelle Kurzrock.
Colaborador(es): Patel, Sandip Pravin, editor literario | Kurzrock, Razelle, editor literario
| SpringerLink (Online service).
Tipo de material: 
E-bookSeries (Current Cancer Research, 2199-2584); (Medicine (Springer-11650)).Editor: Cham : Springer International Publishing : Imprint: Springer, 2018Descripción: 1 recurso en línea (XI, 331 páginas 24 ilustraciones, 15 ilustraciones a color).ISBN: 9783319637570.Tema: Oncología | InmunoterapiaRecursos en línea: Acceso a este recurso digital (usuarios Universidad Europea de Valencia)
| Tipo de ítem | Biblioteca actual | Colección | Signatura topográfica | Estado | Fecha de vencimiento | Código de barras | Reserva de ítems | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Valencia Digital Acceso Electrónico (UEV) | Ciencias de la Salud | RC271 .E275 2018 EB (Navegar estantería(Abre debajo)) | Acceso electrónico |
Navegando Valencia Digital estanterías, Ubicación en estantería: Acceso Electrónico (UEV) Cerrar el navegador de estanterías (Oculta el navegador de estanterías)
| RC271 .C46 2021 EB Radiation Oncology Study Guide | RC271 .C66 2020 EB Controversies in Radiation Oncology | RC271 .C87 2020 EB Current Immunotherapeutic Strategies in Cancer | RC271 .E275 2018 EB Early Phase Cancer Immunotherapy | RC271 .E94 2020 EB Exercise Oncology Prescribing Physical Activity Before and After a Cancer Diagnosis | RC271.G45 2008 EB Gene Therapy of Cancer Methods and Protocols | RC271 .H36 2018 EB Handbook of Evidence-Based Radiation Oncology |
Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins -- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy -- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies -- Chapter 4 Radiographic Evaluation of Immunotherapy -- Chapter 5 Cellular Therapy -- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation -- Chapter 7 Early Phase Cancer Immunotherapy -- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators -- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials -- Chapter 10 Thoracic Immunotherapy.
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
No hay comentarios en este titulo.